Skip to main content
Method for immune tolerance induction in patients receiving enzyme replacement therapy for a variety of metabolic disorders

Method for immune tolerance induction in patients receiving enzyme replacement therapy for a variety of metabolic disorders

Unmet Need Genetically based metabolic disorders affect 1 in 2500 births globally and many of these disorders result in an enzyme deficiency. In most cases, a single enzyme is not produced by the body at…

Read More

RXR modulators to improve the efficacy of immunomodulatory agents in multiple myeloma treatment

RXR modulators to improve the efficacy of immunomodulatory agents in multiple myeloma treatment

Unmet Need Multiple myeloma (MM) is the second most common hematological malignancy in the United States. Although current anti-myeloma therapeutics help patients live with the disease for more than 10 years, MM remains an incurable…

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us